Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,321,451 papers from all fields of science
Search
Sign In
Create Free Account
N-ras Genes
Known as:
Oncogene N-RAS
, N ras Oncogenes
, Neuroblastoma RAS Viral Oncogene Homolog
Expand
Human Oncogene N-RAS is a mutated variant of NRAS Gene (RAS Family), which encodes p21 N-Ras Protein, a monomeric GTPase involved in transmembrane…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
1p13
Colorectal Carcinoma
Homo sapiens
NRAS gene
Expand
Broader (1)
Genes, ras
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment
P. Leoncini
,
A. Bertaina
,
+17 authors
R. Garzon
OncoTarget
2016
Corpus ID: 16830706
Juvenile myelomonocytic leukemia (JMML) is an aggressive leukemia of early childhood characterized by aberrant proliferation of…
Expand
2014
2014
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma
G. Zannoni
,
G. Improta
,
+5 authors
F. Fraggetta
Virchows Archiv
2014
Corpus ID: 24764490
Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer with characteristic biological features and…
Expand
2014
2014
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
M. Di Bartolomeo
,
F. Pietrantonio
,
+11 authors
O. B. O. T. M. Group
Targeted oncology
2014
Corpus ID: 51312
There is conflicting evidence on the predictive role of KRAS status when cetuximab is added to oxaliplatin-based regimens. This…
Expand
2012
2012
NRAS Mutations in Noonan Syndrome
Ellen Denayer
,
H. Peeters
,
L. Sevenants
,
M. Derbent
,
J. Fryns
,
E. Legius
Molecular Syndromology
2012
Corpus ID: 38686307
Noonan syndrome is a genetically heterogeneous disorder caused by mutations in PTPN11, SOS1, RAF1 and less frequently in KRAS…
Expand
Review
2011
Review
2011
New Strategies in Metastatic Melanoma: Oncogene-Defined Taxonomy Leads to Therapeutic Advances
K. Flaherty
,
D. Fisher
Clinical Cancer Research
2011
Corpus ID: 10979044
The discovery of BRAF and KIT mutations provided the first basis for a molecular classification of cutaneous melanoma on…
Expand
Highly Cited
2010
Highly Cited
2010
Tumor and Stem Cell Biology Cancer Research A Mouse Model of Melanoma Driven by Oncogenic KRAS
C. Milagre
,
N. Dhomen
,
+4 authors
R. Marais
2010
Corpus ID: 5876894
Authors' Pathology Institute of Note: Sup Research O Correspon Institute of ed Kingdo marais@icr
2009
2009
Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma
Viktória Lázár
,
Szilvia Ecsedi
,
+6 authors
M. Balázs
Modern Pathology
2009
Corpus ID: 21444768
Amplification of the 11q13 chromosomal region is a common event in primary melanomas. Several candidate genes are localized at…
Expand
Highly Cited
2007
Highly Cited
2007
Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice.
C. Parikh
,
Ramesh Subrahmanyam
,
R. Ren
Cancer Research
2007
Corpus ID: 14280627
RAS proteins are small GTPases that play a central role in transducing signals that regulate cell proliferation, survival, and…
Expand
2005
2005
Activated Ras enhances insulin-like growth factor I induction of vascular endothelial growth factor in prostate epithelial cells.
M. Stearns
,
J. Tran
,
M. K. Francis
,
Hong Zhang
,
C. Sell
Cancer Research
2005
Corpus ID: 6826131
Mutations in the three closely related RAS genes, HRAS, KRAS, and NRAS are among the most common mutations found in human cancer…
Expand
1990
1990
Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction
S. Ganguly
,
V. Murty
,
F. Samaniego
,
V. Reuter
,
G. Bosl
,
R. Chaganti
Genes, Chromosomes and Cancer
1990
Corpus ID: 31588408
We have studied 31 male germ cell tumors (GCTs) for probable mutations in codons 12, 13, and 61 of HRAS, KRAS, and NRAS oncogenes…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE